Nikolaus Schultz

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Autonomous Artificial Intelligence Agents for Clinical Decision Making in Oncology	2024	Dyke Ferber Omar S.M. El Nahhas Georg Wölflein Isabella C. Wiest Jan Clusmann Marie-Elisabeth Leßman Sebastian Foersch Jacqueline Lammert Maximilian Tschochohei Dirk Jäger
+ PDF Chat	MITI minimum information guidelines for highly multiplexed tissue images	2022	Denis Schapiro Clarence Yapp Artem Sokolov Sheila M. Reynolds Chen Yuan Damir Sudar Yubin Xie Jeremy Muhlich Raquel Arias-Camison Sarah Arena
+ PDF Chat	Optimal Strategy and Benefit of Pulsed Therapy Depend On Tumor Heterogeneity and Aggressiveness at Time of Treatment Initiation	2022	Deepti Mathur Bradford P. Taylor Walid K. Chatila Howard I. Scher Nikolaus Schultz Pedram Razavi João B. Xavier
+	Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies	2021	Samantha Brown Jessica A. Lavery Ronglai Shen Axel Martin Kenneth L. Kehl Shawn M. Sweeney Eva M. Lepisto Hira Rizvi Caroline G. McCarthy Nikolaus Schultz
+	MITI Minimum Information guidelines for highly multiplexed tissue images	2021	Denis Schapiro Clarence Yapp Artem Sokolov Sheila M. Reynolds Yuan Chen Damir Sudar Yubin Xie Jeremy Muhlich Raquel Arias-Camison Sarah Arena
+	Abstract PO-114: Mathematical modeling of tumor heterogeneity to optimize treatment scheduling and delay the evolution of resistance	2020	Deepti Mathur Bradford P. Taylor Walid K. Chatila Nikolaus Schultz Pedram Razavi João B. Xavier

Common Coauthors

Coauthor	Papers Together
Ethan Cerami	3
Jeremy Muhlich	2
Walid K. Chatila	2
Dana Pe’er	2
Jason R. Swedlow	2
Michael Angelo	2
Garry P. Nolan	2
Madison Tyler	2
Julia L. Drewes	2
David A. Gutman	2
Artem Sokolov	2
Milen Nikolov	2
Daniel T. Merrick	2
Deepti Mathur	2
Clarence Yapp	2
Pedram Razavi	2
John M. Herndon	2
Bradford P. Taylor	2
Peter Bankhead	2
Scott J. Rodig	2
Peter K. Sorger	2
Nils Gehlenborg	2
Denis Schapiro	2
Sheila M. Reynolds	2
Markus D. Herrmann	2
Samouil L. Farhi	2
Sandro Santagata	2
Damir Sudar	2
Matthew Meyerson	2
Jia‐Ren Lin	2
Raquel Arias-Camison	2
Nithya Venkatamohan	2
M Snyder	2
João B. Xavier	2
Vésteinn Thórsson	2
Joseph T. Roland	2
Hira Rizvi	1
John M. Maris	1
Katherine S. Panageas	1
Kristina A. Cole	1
Zhibin Lu	1
Daniel M. Quinn	1
Giorgio Gaglia	1
Qiuyin Cai	1
Natalie Stickle	1
Stephen T. Oh	1
Jeffrey Huang	1
Gordon B. Mills	1
Moung Christine	1
Priti Kumari	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Modeling Survival Data: Extending the Cox Model	2000	Terry M. Therneau Patricia M. Grambsch	1
+	Nonparametric tests of the Markov model for survival data	1992	Michael P. Jones John Crowley	1
+	The Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens	2006	Richard Simon Larry Norton	1
+	An elementary approach to modeling drug resistance in cancer	2010	Cristian Tomasetti Doron Levy	1
+	A simple test of independence for truncated data with applications to redshift surveys	1992	Bradley Efron V. Petrosian	1
+	Testing Quasi-Independence of Failure and Truncation Times via Conditional Kendall's Tau	2005	Emily C. Martin Rebecca A. Betensky	1
+ PDF Chat	Eliminating bias due to censoring in Kendall’s tau estimators for quasi-independence of truncation and failure	2013	Matthew Austin Rebecca A. Betensky	1
+ PDF Chat	Rank Regression Methods for Left-Truncated and Right-Censored Data	1991	Tze Leung Lai Zhiliang Ying	1
+	Hazards regression analysis for length-biased data	1996	MC Wang	1
+	Testing the assumption of independence of truncation time and failure time	1990	Wei Yann Tsai	1
+	Emergence of a Subpopulation in a Computational Model of Tumor Growth	2000	M. Feldman Salvatore Torquato E. Antonio Chiocca Thomas S. Deisboeck	1
+ PDF Chat	Impact of genetic dynamics and single-cell heterogeneity on development of nonstandard personalized medicine strategies for cancer	2012	Robert A. Beckman Gunter S. Schemmann Chen-Hsiang Yeang	1
+ PDF Chat	Survival Analysis Using SAS: A Practical Guide. Second Edition By Paul D. Allison	2011	Nora E. Rosenberg L. Sirkus	1
+	Evolutionary dynamics of cancer in response to targeted combination therapy	2013	Ivana Božić Johannes G. Reiter Benjamin Allen Tibor Antal Krishnendu Chatterjee Preya Shah Yo Sup Moon Amin Yaqubie Nicole Kelly Dung T. Le	1
+ PDF Chat	Threats to Validity of Nonrandomized Studies of Postdiagnosis Exposures on Cancer Recurrence and Survival	2013	Jessica Chubak Denise M. Boudreau Heidi S. Wirtz Barbara McKnight Noel S. Weiss	1
+	Evolutionary Approaches to Prolong Progression-Free Survival in Breast Cancer	2012	Ariosto S. Silva Yoonseok Kam Zayar P. Khin Susan Minton Robert J. Gillies Robert A. Gatenby	1
+ PDF Chat	Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity	2014	Vanessa Almendro Yu-Kang Cheng Amanda Randles Shalev Itzkovitz Andriy Marusyk Elisabet Ametller Xavier González Montse Muñoz Hege G. Russnes Åslaug Helland	1
+	Bias Due to Left Truncation and Left Censoring in Longitudinal Studies of Developmental and Disease Processes	2011	Kevin C. Cain Sioḃán D. Harlow Roderick J. A. Little Bin Nan Matheos Yosef John Taffe Michael R. Elliott	1
+ PDF Chat	Survival Analysis Techniques for Censored and Truncated Data	1998	Marepalli B. Rao John P. Klein Melvin L. Moeschberger	1
+ PDF Chat	Accuracy Loss Due to Selection Bias in Cohort Studies with Left Truncation	2013	Enrique F. Schisterman Stephen R. Cole Aijun Ye Robert W. Platt	1
+	Improving Cancer Treatment via Mathematical Modeling: Surmounting the Challenges Is Worth the Effort	2015	Franziska Michor Kathryn Beal	1
+ PDF Chat	Recognizing the problem of delayed entry in time‐to‐event studies: Better late than never for clinical neuroscientists	2015	Rebecca A. Betensky Micha Mandel	1
+ PDF Chat	Mathematical Modeling of Therapy-induced Cancer Drug Resistance: Connecting Cancer Mechanisms to Population Survival Rates	2016	Xiaoqiang Sun Jiguang Bao Yongzhao Shao	1
+ PDF Chat	A General Framework for Considering Selection Bias in EHR-Based Studies: What Data are Observed and Why?	2016	Sebastien Haneuse Michael J. Daniels	1
+ PDF Chat	Long range personalized cancer treatment strategies incorporating evolutionary dynamics	2016	Chen-Hsiang Yeang Robert A. Beckman	1
+	Pharmacokinetics and Drug Interactions Determine Optimum Combination Strategies in Computational Models of Cancer Evolution	2017	Shaon Chakrabarti Franziska Michor	1
+ PDF Chat	Modeling the Subclonal Evolution of Cancer Cell Populations	2017	Diego Chowell James Napier Rohan Gupta Karen S. Anderson Carlo C. Maley Melissa A. Wilson Sayres	1
+ PDF Chat	Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients	2018	Shayna Stein Rui Zhao Hiroshi Haeno Igor Vivanco Franziska Michor	1
+ PDF Chat	Transformation model estimation of survival under dependent truncation and independent censoring	2018	Sy Han Chiou Matthew Austin Jing Qian Rebecca A. Betensky	1
+ PDF Chat	Dynamic Targeting in Cancer Treatment	2019	Zhihui Wang Thomas S. Deisboeck	1
+ PDF Chat	The human body at cellular resolution: the NIH Human Biomolecular Atlas Program	2019	M Snyder Shin Lin Amanda L. Posgai Mark A. Atkinson Aviv Regev Jennifer Rood Orit Rozenblatt–Rosen Leslie Gaffney Anna Hupalowska Rahul Satija	1
+	Stochastic Evolution of Pancreatic Cancer Metastases During Logistic Clonal Expansion	2019	Kimiyo N. Yamamoto Lin Liu Akira Nakamura Hiroshi Haeno Franziska Michor	1
+	Modelling bistable tumour population dynamics to design effective treatment strategies	2019	Andrei R. Akhmetzhanov Jong Wook Kim Ryan J. Sullivan Robert A. Beckman Pablo Tamayo Chen‐Hsiang Yeang	1
+	Optimal Therapy Scheduling Based on a Pair of Collaterally Sensitive Drugs	2018	Nara Yoon Robert Vander Velde Andriy Marusyk Jacob G. Scott	1
+	Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies	2018	Jill Gallaher Pedro M. Enríquez‐Navas Kimberly A. Luddy Robert A. Gatenby Alexander R.A. Anderson	1
+ PDF Chat	Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution	2017	Vanessa D. Jönsson Collin M. Blakely Luping Lin Saurabh Asthana Nikolai Matni Victor Olivas Evangelos Pazarentzos Matthew A. Gubens Boris C. Bastian Barry S. Taylor	1
+	Mathematical Approach to Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment	2019	James M. Greene Jana L. Gevertz Eduardo D. Sontag	1
+ PDF Chat	A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors	2019	Anyue Yin Dirk Jan A. R. Moes J. G. Coen van Hasselt Jesse J. Swen Henk‐Jan Guchelaar	1
+ PDF Chat	The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just Right	2019	Derek S. Park Mark Robertson‐Tessi Kimberly A. Luddy Philip K. Maini Michael B. Bonsall Robert A. Gatenby Alexander R.A. Anderson	1
+ PDF Chat	Dataset search in biodiversity research: Do metadata in data repositories reflect scholarly information needs?	2021	Felicitas Löffler Valentin Wesp Birgitta König‐Ries Friederike Klan	1
+ PDF Chat	How Should Cancer Models Be Constructed?	2020	Robert A. Beckman Irina Kareva Frederick R. Adler	1
+	A Global View of Standards for Open Image Data Formats and Repositories	2020	Jason R. Swedlow Pasi Kankaanpää Uğis Sarkans Wojtek Goscinski Graham J. Galloway Ryan P. Sullivan Claire M. Brown Chris Wood Antje Keppler Ben Loos	1
+ PDF Chat	Using association rule mining and ontologies to generate metadata recommendations from multiple biomedical databases	2019	Marcos Martínez-Romero Martin J. O’Connor Attila L. Egyedi Debra Willrett Josef Hardi John Graybeal Mark A. Musen	1
+ PDF Chat	Guidelines for reporting single-cell RNA-seq experiments	2020	Anja Füllgrabe Nancy George Matthew Green Parisa Nejad Bruce J. Aronow Silvie Fexová Clay Fischer Mallory Freeberg Laura Huerta Norman Morrison	1
+	Transformation Model Based Estimation of Survival and Regression Under Dependent Truncation and Independent Censoring [R package tranSurv version 1.2.2]	2021	Sy Han Chiou Jing Qian	1
+ PDF Chat	A global view of standards for open image data formats and repositories	2021	Jason R. Swedlow Pasi Kankaanpää Uğis Sarkans Wojtek Goscinski Graham J. Galloway Leonel Malacrida Ryan P. Sullivan Steffen Härtel Claire M. Brown Christopher D. Wood	1
+ PDF Chat	QUAREP‐LiMi: A community‐driven initiative to establish guidelines for quality assessment and reproducibility for instruments and images in light microscopy	2021	Glyn Nelson Ulrike Boehm Steve Bagley Peter Bajcsy Johanna Bischof Claire M. Brown Aurélien Dauphin Ian M. Dobbie John Eriksson Orestis Faklaris	1
+	Adaptive Therapy	2009	Robert A. Gatenby Ariosto S. Silva Robert J. Gillies B. Roy Frieden	1
+ PDF Chat	Resisting Resistance	2016	Ivana Božić Martin A. Nowak	1